Tagged with Hong Kong

Hong Kong Professor James Chim, chairman and founder of the Hong Kong Society of Myeloma, shares the history and key objectives of the organization. He also elaborates on the recent milestones achieved regarding the treatment of the rare disease. Can you begin by introducing the Hong Kong Society of Myeloma and what…

Hong Kong Hye-ja Kim, Pfizer Pharmaceutical Innovative Health (Hong Kong and Macau Lead), shares how Pfizer’s global achievements in 2017 are reflected within the Hong Kong affiliate, the innovative solutions they can offer Hong Kong patients, government and other healthcare stakeholders beyond just a drug, and their continued commitment to extending their…

Hong Kong Dr. Sze-fai YIP, Chairman of the Hong Kong Society of Haematology (HKSH), shares the mission of the society to support healthcare professionals and other stakeholders within the area of haematology in order to drive better health outcomes, the challenges faced by haematology patients in Hong Kong, and the potential of…

Hong Kong Prof. Michael Yang, an accomplished scientist and start-up expert, introduces the goals of the fast-growing Biomedical Sciences Department of City University Hong Kong. He unveils the contribution of Hong Kong to the Greater Bay Area in the biomedical field, while analyzing the key elements to change so the region can…

Hong Kong Ian Huen, founder and CEO of Aptorum Group, discusses why Hong Kong was the ideal location to base the company, its exciting development pipeline and his unique management philosophy. Ian, with your asset management background, could you share what inspired you to establish Aptorum Group in 2016? My biotech journey…

Hong Kong Colman Chan, CEO of ophthalmology specialist Skyview Optical, outlines recent developments in the Hong Kong eyecare market, Skyview’s evolution as a distributor and how it can foster greater links with Mainland China. What have been some of Skyview Optical’s main achievements and milestones since its establishment? Since creating the company…

Hong Kong Professor Anne W.M. Lee, vice chairman of the Hong Kong Anti-Cancer Society, discusses the role of patient associations in driving change within healthcare systems. Professor Lee, could you perhaps start by sharing the current strategic priorities of the Hong Kong Anti-Cancer Society (HKACS)? As the biggest non-government organization (NGO) in…

Japan It is said that ostriches have the strongest immune system of any animal in the world. Because of this, they have shown great promise in preventative healthcare in humans and the beauty industry. The antibodies are resistant to higher pH levels and can remain active even when exposed to heat…

Hong Kong Dr. Daniel Thurley, general manager of Roche Hong Kong and Macau, shares his first impressions of the affiliate, the strategic significance of Hong Kong to Roche globally, the innovative medicines and technology Roche is committed to bringing to Hong Kong, and his insights on Roche’s commitment to patient-centricity. There have…

China Simon Yam, managing director of Geodis Greater China, shares the importance of the Greater China region to Geodis globally, the region’s strong performance and growth, the strategic importance of the healthcare and life sciences sector to their business, and the value-added, niche services and solutions they are committed to offering…

Hong Kong Winnie Lun and Dr. Patrick Leung, CEO and CSO of eNano Health, shares the serendipitous story of how they came to establish eNano Health in Hong Kong in 2010; their first flagship product, the Kiss and Tell Glucose Meter, and their expansion into other diagnostic areas; as well as their…

Hong Kong Gene Shigekawa, managing partner of MAZ World, shares their recent move to the Hong Kong Science and Technology Park (HKSTP) in 2017, the revolutionary ostrich-derived antibody they hope to further develop and commercialize, the strengths of Hong Kong as a biotech base for start-ups, and the huge potential for their…